Treatment outcomes of prostate cancer patients with Gleason score  8–10 treated with definitive radiotherapy

ConclusionsOur results validated the fact that oncologic outcomes after radical EBRT significantly differ in men with GS  8 versus those with GS 9–10 prostate cancer. We found that EBRT dose was important predictive factor regardless of ADT period. Patients receiving ‘non-optimal treatment’ (RT doses<78  Gy and ADT period<2  years) had the worst treatment outcomes.
Source: Strahlentherapie und Onkologie - Category: Cancer & Oncology Source Type: research